Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 apiece, ...
Boundless Bio’s announcement earlier this month of plans to go public was a sign that the biotech IPO window hadn’t slammed shut after a flurry of offerings at the start of the year. Now, the company ...
Zacks Investment Research on MSN
Boundless Bio, Inc. (BOLD) upgraded to buy: Here's why
Boundless Bio, Inc. (BOLD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Editor’s note: This is part of a series profiling six of the Seattle region’s “Uncommon Thinkers”: inventors, scientists, technologists and entrepreneurs transforming industries and driving positive ...
Two years ago, former Amazon product manager Xiao Wang stood on the stage at TechCrunch Disrupt San Francisco and made the case for a platform meant to help couples apply for marriage green cards, a ...
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Apr 22, 2021 at ...
Boundless Group has filed for an initial public offering. The Chinese optical display technology company said it will sell 4 million units at $4 to $5 apiece, according to a filing with the Securities ...
Boundless may appear at first glance to be a Minecraft clone. It has a similar core gameplay loop, to be sure. Players must collect nearby resources to craft things such as crafting tables, furnaces, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results